Policy & Legislation News on government policy and legislation impacting life science and diagnostics. Sep 9, 2022 In Brief This Week: Strata Oncology, SEngine Precision Medicine, Cancer Care Is Different Coalition Aug 18, 2022 CHOP, NCI Launch Big Data Resource to Spur Precision Pediatric Cancer Drug Development Premium Jul 29, 2022 AstraZeneca Q2 Oncology Sales Grow 14 Percent as Firm Awaits Key Precision Drug Regulatory Decisions Premium Jul 29, 2022 Policy Changes Needed to Address Biomarker Testing Disparities for Medicaid Patients, Experts Say Premium Jul 28, 2022 Merck's Keytruda Q2 Sales Grow 26 Percent; Firm Considers Future Impact of Medicare Price Setting Premium Jul 1, 2022 In Brief This Week: Lungevity, Grail, Mainz Biomed, Bayer, Scorpion, Caris Life Sciences May 25, 2022 California Bill to Improve Precision Cancer Care Access for Medi-Cal Patients Sails Through Senate May 20, 2022 FDA, Industry Look to Congress to Reauthorize User-Fee Act, Improve Cell Therapy Regulation Premium Apr 29, 2022 California Bill Aims to Give Medi-Cal Patients With Complex Cancers Access to Cutting-Edge Care Premium Apr 13, 2022 RACE for Children Act Spurs Pharma to Study Molecularly Informed Drugs in Pediatric Cancer Patients Premium Oct 13, 2021 California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law Aug 5, 2021 State-Regulated Illinois Health Plans Subject to Biomarker Test Coverage Mandate Starting 2022 Premium Jul 27, 2021 Healthcare Providers Adjust to Anti-Information Blocking Regulation Impact on Patient Interactions Premium Apr 11, 2021 NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths Sep 11, 2020 UK's NICE Backs Tagrisso for First-, Second-Line EGFR-Positive Lung Cancer May 12, 2020 NICE, NHS England's Pandemic Guideline Gives Temporary Access to Precision Oncology Treatments Premium Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Jan 22, 2020 UK's NICE Will Not Recommend Osimertinib for Untreated Non-Small Cell Lung Cancer Dec 13, 2019 FDA Issues Draft Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs Sep 16, 2019 UK-Led Team Pushes for Broader BRCA Screening Policies With Data on Ashkenazi Population Premium Load More Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
